v3.26.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-In Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2023   290,411,000      
Beginning balance at Mar. 31, 2023 $ 1,604,869 $ 290 $ 1,989,797 $ (353,389) $ (31,829)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (3,570)       (3,570)
Restricted stock units vested (in shares)   4,376,000      
Restricted stock units vested 0 $ 4 (4)    
Restricted stock awards granted (in shares)   142,000      
Issuance of common stock related to employee stock purchase plan (in shares)   534,000      
Issuance of common stock related to employee stock purchase plan 19,472 $ 1 19,471    
Exercise of stock options (in shares)   1,500,000      
Exercise of stock options 31,191 $ 2 31,189    
Share-based compensation 208,896   208,896    
Net income 154,632     154,632  
Ending balance (in shares) at Mar. 31, 2024   296,963,000      
Ending balance at Mar. 31, 2024 2,015,490 $ 297 2,249,349 (198,757) (35,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) 757       757
Restricted stock units vested (in shares)   5,228,000      
Restricted stock units vested 0 $ 5 (5)    
Issuance of common stock related to employee stock purchase plan (in shares)   531,000      
Issuance of common stock related to employee stock purchase plan 21,159   21,159    
Exercise of stock options (in shares)   932,000      
Exercise of stock options 20,995 $ 1 20,994    
Share-based compensation 271,703   271,703    
Shares withheld for employee taxes (in shares)   (394,000)      
Shares withheld for employee taxes (20,022)   (20,022)    
Repurchases of common stock (in shares)   (3,447,000)      
Repurchases of common stock (172,618) $ (3) (172,615)    
Net income $ 483,684     483,684  
Ending balance (in shares) at Mar. 31, 2025 299,813,048 299,813,000      
Ending balance at Mar. 31, 2025 $ 2,621,148 $ 300 2,370,563 284,927 (34,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) (1,353)       (1,353)
Restricted stock units vested (in shares)   5,679,000      
Restricted stock units vested 0 $ 6 (6)    
Restricted stock awards granted (in shares)   41,000      
Issuance of common stock related to employee stock purchase plan (in shares)   585,000      
Issuance of common stock related to employee stock purchase plan $ 24,390   24,390    
Exercise of stock options (in shares) 315,000 315,000      
Exercise of stock options $ 6,487   6,487    
Share-based compensation 299,626   299,626    
Shares withheld for employee taxes (in shares)   (422,000)      
Shares withheld for employee taxes (21,138)   (21,138)    
Repurchases of common stock (in shares)   (11,358,000)      
Repurchases of common stock (480,439) $ (11) (480,428)    
Net income $ 162,669     162,669  
Ending balance (in shares) at Mar. 31, 2026 294,652,951 294,653,000      
Ending balance at Mar. 31, 2026 $ 2,611,390 $ 295 $ 2,199,494 $ 447,596 $ (35,995)